A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants

NCT06869018 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Type 2 Diabetes Mellitus (T2D)

Interventions

DRUG: LY3549492
DRUG: Placebo

Sponsor

Eli Lilly and Company